Article Type
Review
Published
This article examines the major approaches to immunotherapy in breast cancers, both successes and failures, as well as new therapies on the horizon.
Review
This article examines the major approaches to immunotherapy in breast cancers, both successes and failures, as well as new therapies on the horizon.
Original Research
This article examines the relationship between U.S. Food and Drug Administration (FDA) approval and the publication of OS evidence to understand better the risks and benefits of delaying approval until OS evidence is available.
Original Research
This retrospective study looks to find specific predictive criteria related to patient or tumor characteristics in order to select patients that might benefit the most from eribulin and define the correct treatment sequence.
Case Report
The authors report a case of primary prostate and lung tumors associated with gastric and small bowel GISTs, unrelated to any known hereditary syndrome.
Original Research
This article reports on the case of a young papillary thyroid cancer patient, pretreated with three other kinase inhibitors, who achieved a long-term clinical benefit from lenvatinib in the fourth-line setting.